Grantham, Mayo, Van Otterloo & Co (GMO)’s Varex Imaging VREX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio VREX Stock Details VREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,183	Closed	-$264K	–	694
2023 Q2	$264K	Buy	+11,183	New	+$233K	﹤0.01%	621
2022 Q3	–	Sell	-65,700	Closed	-$1.41M	–	798
2022 Q2	$1.41M	Sell	65,700 -58,600	-47%	-$1.25M	0.01%	480
2022 Q1	$2.65M	Buy	124,300 +33,300	+37%	+$847K	0.01%	414
2021 Q4	$2.87M	Buy	91,000 +19,500	+27%	+$553K	0.01%	414
2021 Q3	$2.02M	Buy	+71,500	New	+$1.98M	0.01%	453
2020 Q4	–	Sell	-60,600	Closed	-$771K	–	890
2020 Q3	$771K	Sell	60,600 -59,500	-50%	-$814K	0.01%	565
2020 Q2	$1.82M	Buy	120,100 +37,900	+46%	+$765K	0.01%	435
2020 Q1	$1.87M	Sell	82,200 -63,500	-44%	-$1.64M	0.02%	388
2019 Q4	$4.34M	Sell	145,700 -8,300	-5%	-$248K	0.03%	306
2019 Q3	$4.39M	Buy	+154,000	New	+$4.46M	0.03%	317

Other funds holding VREX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s VREX Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Varex Imaging (VREX) in Q3 2023, closing a stake of 11,183 shares — an estimated $264K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VREX in Q3 2019 and held it in 10 quarters. The position peaked at $4.39M in Q3 2019. 187 funds tracked by Wall St. Rank hold VREX as of Q3 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Varex Imaging position as of Q3 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,183 Varex Imaging shares in Q3 2023, an estimated $264K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Varex Imaging in Q3 2019 and held it in 10 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Varex Imaging position peaked at $4.39M in Q3 2019.
187 funds tracked by Wall St. Rank held Varex Imaging as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.